Telomerase and cancer therapeutics
- 1 March 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Cancer
- Vol. 8 (3), 167-179
- https://doi.org/10.1038/nrc2275
Abstract
Telomerase is an attractive cancer target as it appears to be required in essentially all tumours for immortalization of a subset of cells, including cancer stem cells. Moreover, differences in telomerase expression, telomere length and cell kinetics between normal and tumour tissues suggest that targeting telomerase would be relatively safe. Clinical trials are ongoing with a potent and specific telomerase inhibitor, GRN163L, and with several versions of telomerase therapeutic vaccines. The prospect of adding telomerase-based therapies to the growing list of new anticancer products is promising, but what are the advantages and limitations of different approaches, and which patients are the most likely to respond?Keywords
This publication has 134 references indexed in Scilit:
- Telomerase and its potential for therapeutic interventionBritish Journal of Pharmacology, 2007
- Human Cancer Cells Harbor T-Stumps, a Distinct Class of Extremely Short TelomeresMolecular Cell, 2007
- Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNature Reviews Immunology, 2007
- Telomere length is paternally inherited and is associated with parental lifespanProceedings of the National Academy of Sciences of the United States of America, 2007
- Telomerase induction in T cells: A cure for aging and disease?Experimental Gerontology, 2007
- Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanismBritish Journal of Cancer, 2007
- Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II studyBritish Journal of Cancer, 2006
- A DNA damage checkpoint response in telomere-initiated senescenceNature, 2003
- The Hallmarks of CancerCell, 2000
- Telomeres shorten during ageing of human fibroblastsNature, 1990